2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards.
作者信息
Bozkurt Biykem, Das Sandeep R, Addison Daniel, Gupta Aakriti, Jneid Hani, Khan Sadiya S, Koromia George Augustine, Kulkarni Prathit A, LaPoint Kathleen, Lewis Eldrin F, Michos Erin D, Peterson Pamela N, Turagam Mohit K, Wang Tracy Y, Yancy Clyde W
出版信息
J Am Coll Cardiol. 2022 Jul 26;80(4):388-465. doi: 10.1016/j.jacc.2022.03.355. Epub 2022 Jun 23.
Abstract
摘要
相似文献
1
2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards.
J Am Coll Cardiol. 2022 Jul 26;80(4):388-465. doi: 10.1016/j.jacc.2022.03.355. Epub 2022 Jun 23.
2
2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards.
Circ Cardiovasc Qual Outcomes. 2022 Jul;15(7):e000111. doi: 10.1161/HCQ.0000000000000111. Epub 2022 Jun 23.
3
2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure).
Circ Cardiovasc Qual Outcomes. 2021 Apr;14(4):e000102. doi: 10.1161/HCQ.0000000000000102. Epub 2021 Mar 23.
4
2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure).
J Am Coll Cardiol. 2021 Apr 27;77(16):2053-2150. doi: 10.1016/j.jacc.2020.11.012. Epub 2020 Nov 26.
5
2019 ACC/AHA/ASE Key Data Elements and Definitions for Transthoracic Echocardiography: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Transthoracic Echocardiography) and the American Society of Echocardiography.
J Am Soc Echocardiogr. 2019 Sep;32(9):1161-1248. doi: 10.1016/j.echo.2019.05.006. Epub 2019 Jun 24.
6
2019 ACC/AHA/ASE Key Data Elements and Definitions for Transthoracic Echocardiography: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards) and the American Society of Echocardiography.
Circ Cardiovasc Imaging. 2019 Jul;12(7):e000027. doi: 10.1161/HCI.0000000000000027. Epub 2019 Jun 24.
7
2017 AHA/ACC Key Data Elements and Definitions for Ambulatory Electronic Health Records in Pediatric and Congenital Cardiology: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards.
J Am Coll Cardiol. 2017 Aug 22;70(8):1029-1095. doi: 10.1016/j.jacc.2017.06.027. Epub 2017 Jul 14.
8
ACC/AHA 2013 methodology for developing clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards.
J Am Coll Cardiol. 2014 Jun 3;63(21):2323-34. doi: 10.1016/j.jacc.2013.11.006. Epub 2013 Nov 15.
9
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards).
J Am Coll Cardiol. 2015 Jul 28;66(4):403-69. doi: 10.1016/j.jacc.2014.12.018. Epub 2014 Dec 29.
10
2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS Key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to develop Clinical Data Standards for peripheral atherosclerotic vascular disease).
J Am Coll Cardiol. 2012 Jan 17;59(3):294-357. doi: 10.1016/j.jacc.2011.10.860. Epub 2011 Dec 5.
引用本文的文献
1
Long-term outcomes of patients with pre-existing coronary artery disease after SARS-CoV-2 infection.
EBioMedicine. 2025 Jun;116:105778. doi: 10.1016/j.ebiom.2025.105778. Epub 2025 May 28.
2
Long-term cardiovascular disease outcomes in non-hospitalized medicare beneficiaries diagnosed with COVID-19: Population-based matched cohort study.
PLoS One. 2024 May 14;19(5):e0302593. doi: 10.1371/journal.pone.0302593. eCollection 2024.
3
Different clinical characteristics and outcomes of adult hospitalized SARS-CoV-2 pneumonia patients complicated by cardiovascular events during the first, delta and omicron waves of COVID-19.
Front Epidemiol. 2024 Apr 18;4:1342917. doi: 10.3389/fepid.2024.1342917. eCollection 2024.
4
A Post-Pandemic Enigma: The Cardiovascular Impact of Post-Acute Sequelae of SARS-CoV-2.
Circ Res. 2023 May 12;132(10):1358-1373. doi: 10.1161/CIRCRESAHA.122.322228. Epub 2023 May 11.
5
An electrophysiological substrate of COVID-19.
J Electrocardiol. 2023 Jul-Aug;79:61-65. doi: 10.1016/j.jelectrocard.2023.03.010. Epub 2023 Mar 20.
6
Objective Hemodynamic Cardiovascular Autonomic Abnormalities in Post-Acute Sequelae of COVID-19.
Can J Cardiol. 2023 Jun;39(6):767-775. doi: 10.1016/j.cjca.2022.12.002. Epub 2022 Dec 9.
7
Myocardial Injuries in COVID-19: More Questions Than Answers.
J Clin Med. 2022 Aug 3;11(15):4527. doi: 10.3390/jcm11154527.
本文引用的文献
1
Stroke Among Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry.
Stroke. 2022 Mar;53(3):800-807. doi: 10.1161/STROKEAHA.121.035270. Epub 2021 Oct 27.
2
Cardiovascular magnetic resonance evaluation of soldiers after recovery from symptomatic SARS-CoV-2 infection: a case-control study of cardiovascular post-acute sequelae of SARS-CoV-2 infection (CV PASC).
J Cardiovasc Magn Reson. 2021 Oct 7;23(1):106. doi: 10.1186/s12968-021-00798-1.
3
Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome.
Am J Med. 2021 Dec;134(12):1451-1456. doi: 10.1016/j.amjmed.2021.07.004. Epub 2021 Aug 11.
4
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.
N Engl J Med. 2021 Aug 26;385(9):777-789. doi: 10.1056/NEJMoa2103417. Epub 2021 Aug 4.
5
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
N Engl J Med. 2021 Aug 26;385(9):790-802. doi: 10.1056/NEJMoa2105911. Epub 2021 Aug 4.
6
Post-acute Sequelae of SARS-CoV-2 Infection and Subjective Memory Problems.
JAMA Netw Open. 2021 Jul 1;4(7):e2119335. doi: 10.1001/jamanetworkopen.2021.19335.
7
Association Between COVID-19 Exposure and Self-reported Compliance With Public Health Guidelines Among Essential Employees at an Institution of Higher Education in the US.
JAMA Netw Open. 2021 Jul 1;4(7):e2116543. doi: 10.1001/jamanetworkopen.2021.16543.
8
Myocarditis With COVID-19 mRNA Vaccines.
Circulation. 2021 Aug 10;144(6):471-484. doi: 10.1161/CIRCULATIONAHA.121.056135. Epub 2021 Jul 20.
9
Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System.
Pharmaceuticals (Basel). 2021 Jun 25;14(7):611. doi: 10.3390/ph14070611.
10
The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
Curr Neurol Neurosci Rep. 2021 Jun 28;21(9):44. doi: 10.1007/s11910-021-01130-1.
Zotero 插件